103 related articles for article (PubMed ID: 20497005)
21. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
[TBL] [Abstract][Full Text] [Related]
22. Saponins from Rubus parvifolius L. induce apoptosis in human chronic myeloid leukemia cells through AMPK activation and STAT3 inhibition.
Ge YQ; Xu XF; Yang B; Chen Z; Cheng RB
Asian Pac J Cancer Prev; 2014; 15(13):5455-61. PubMed ID: 25041018
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of eukaryotic initiation factor 3B suppresses proliferation and promotes apoptosis of chronic myeloid leukemia cells.
Huang L; He K; Wang J; Yan J; Jiang Y; Wei Z; Zhang J; Li G; Sheng L
Adv Clin Exp Med; 2019 Dec; 28(12):1639-1645. PubMed ID: 31778600
[TBL] [Abstract][Full Text] [Related]
24. Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.
Zhang JH; He YL; Zhu R; Du W; Xiao JH
Tumour Biol; 2017 Jun; 39(6):1010428317713394. PubMed ID: 28639894
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.
Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q
Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465
[TBL] [Abstract][Full Text] [Related]
26. miRNA-301a induces apoptosis of chronic myelogenous leukemia cells by directly targeting TIMP2/ERK1/2 and AKT pathways.
Huang X; Qi L; Lu W; Yang G; Chen Y; Zhang R; Rao J; Ji D; Huang R; Chen G
Oncol Rep; 2017 Feb; 37(2):945-952. PubMed ID: 28035415
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of HDAC3 and STAT3 is critically involved in 1-stearoyl-sn-glycero-3-phosphocholine-induced apoptosis in chronic myelogenous leukemia K562 cells.
Jung JH; Jeong SJ; Kim JH; Jung SK; Jung DB; Lee D; Sohn EJ; Yun M; Lee HJ; Lee HJ; Kim SH
Cell Biochem Biophys; 2013; 67(3):1379-89. PubMed ID: 23729004
[TBL] [Abstract][Full Text] [Related]
28. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines.
Sumita N; Bito T; Nakajima K; Nishigori C
Exp Dermatol; 2006 Apr; 15(4):291-9. PubMed ID: 16512876
[TBL] [Abstract][Full Text] [Related]
29. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
Farhadi E; Zaker F; Safa M; Rezvani MR
Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
[TBL] [Abstract][Full Text] [Related]
30. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization and prognostic significance of FLT3 in CML progression.
Kim KI; Park J; Ahn KS; Won NH; Kim BK; Shin WG; Yoon SS; Oh JM
Leuk Res; 2010 Aug; 34(8):995-1001. PubMed ID: 20031210
[TBL] [Abstract][Full Text] [Related]
32. Study on the treatment of the p15 gene combined with Bcr-abl-specific siRNA and STI571 for chronic myeloid leukemia.
Wang W; Du Y; Li NN; Lv FF; Lin GQ
Genet Mol Res; 2014 May; 13(2):4089-101. PubMed ID: 24938701
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70.
Chakraborty PK; Mustafi SB; Ganguly S; Chatterjee M; Raha S
Cancer Sci; 2008 Jun; 99(6):1109-16. PubMed ID: 18429957
[TBL] [Abstract][Full Text] [Related]
34. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
Della Peruta M; Martinelli G; Moratti E; Pintani D; Vezzalini M; Mafficini A; Grafone T; Iacobucci I; Soverini S; Murineddu M; Vinante F; Tecchio C; Piras G; Gabbas A; Monne M; Sorio C
Cancer Res; 2010 Nov; 70(21):8896-906. PubMed ID: 20959494
[TBL] [Abstract][Full Text] [Related]
35. Modification of Gene Expression, Proliferation, and Function of OP9 Stroma Cells by Bcr-Abl-Expressing Leukemia Cells.
Supper E; Tahir S; Imai T; Inoue J; Minato N
PLoS One; 2015; 10(7):e0134026. PubMed ID: 26218064
[TBL] [Abstract][Full Text] [Related]
36. Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation.
Rangatia J; Bonnet D
Leukemia; 2006 Jan; 20(1):68-76. PubMed ID: 16281073
[TBL] [Abstract][Full Text] [Related]
37. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
38. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
[TBL] [Abstract][Full Text] [Related]
39. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
[TBL] [Abstract][Full Text] [Related]
40. A small molecule significantly inhibits the bcr/abl fusion gene at the mRNA level in human chronic myelogenous leukemia.
He Q; Dong J; Zhen H; Ying Y; Zhang J; Li Q; Li B; Zhou Y
Leuk Res; 2011 Aug; 35(8):1074-9. PubMed ID: 21163528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
